ClinicalTrials.Veeva

Menu

Effect of Mandala Practice on Menopausal Symptoms and Quality of Life

E

Emine Karacan

Status

Not yet enrolling

Conditions

Quality of Life
Menopausal Symptoms
Menopause Symptom Management

Treatments

Other: Mandala coloring

Study type

Interventional

Funder types

Other

Identifiers

NCT07149285
Protocol No:2025/523

Details and patient eligibility

About

Menopause is a natural cycle of life that mostly develops due to changes in the endocrine glands of the female body during middle age, and the menstrual cycle is permanently interrupted as a result of the ovaries losing their activity. Many symptoms are observed in women during menopause, and these symptoms cause women to experience many physiological, mental, social and sexual problems in the short or long term and to deteriorate their quality of life. In reducing the menopause symptoms experienced by women, hormone replacement therapy, traditional methods, mental or physical applications; aromatherapy, hypnosis, Biofeedback and relaxation techniques are used. The aim of these applications; is to relax women, reduce menopausal symptoms and increase their quality of life. Mandala, which has been widely used in the field of therapy in the past and today, is seen as a meditation tool in art therapy and is defined as a complementary, safe and accessible activity that supports mental health. It has been determined that how the mandala method, which is used in many areas in the literature, affects the symptoms and quality of life of women in the menopausal period has not been examined. For this reason, it is thought that this study will make a significant contribution to the literature.

Full description

This study was designed as a randomized controlled experimental trial to examine the effects of mandala practice on menopausal symptoms and quality of life. The study will be conducted with 78 women (experimental = 39, control = 39) diagnosed with menopause at the Private Palmiye Hospital Gynecology and Obstetrics Outpatient Clinics. Participants will be randomly assigned to groups via random.org. Women in the experimental group will practice mandala coloring for 20-30 minutes daily for 15 days, while the control group will only be administered the scales and will be advised to practice mandala practice at the end of the study due to ethical principles. Data will be collected using a Personal Information Form, the Menopause Symptoms Assessment Scale, the Menopause-Specific Quality of Life Scale, and the Mandala Practice Follow-up Form. Data will be analyzed using frequency, descriptive statistics, the Shapiro-Wilks normality test, the independent samples t-test, one-way analysis of variance, and the Pearson correlation test in SPSS 24.0. It is anticipated that the findings of the study will make a significant contribution to the literature by revealing the effect of mandala practice in reducing symptoms and improving quality of life in menopausal women.

Enrollment

78 estimated patients

Sex

Female

Ages

40 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The study included women who met the following conditions:
  2. Absence of cognitive, hearing, or speech impairments that could interfere with effective communication,
  3. No physical, psychological, or visual limitations that could hinder participation in mandala coloring activities,
  4. Literacy in Turkish, including the ability to read, comprehend, and write,
  5. A confirmed medical diagnosis of menopause,
  6. Not undergoing any form of psychotherapy or alternative treatment throughout the study period,
  7. Voluntary participation with signed informed consent.

Exclusion criteria

  1. Participants were excluded from the study if they:
  2. Provided incomplete or inaccurate responses in the data collection forms,
  3. Were receiving hormone therapy to manage menopausal symptoms,
  4. Had a neurological disorder that could impair concentration or communication during the mandala activity,
  5. Had known allergies to paints or similar substances.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

78 participants in 2 patient groups

Intervention Group
Experimental group
Description:
Intervention Group: Women diagnosed with menopause will be invited to the study through face-to-face interviews at the outpatient clinic. Information will be provided about the study and the mandala application; women who agree to participate in the study will be asked to fill out an informed consent form, personal information form, menopause symptoms and menopause-specific quality of life assessment scales. Sample mandalas, blank mandalas, 12 different color crayons and a mandala application follow-up form will be distributed to the participants. The mandala application will be performed by the participants for 20-30 minutes every day for 15 days. In the interim periods (every other day), the application will be monitored by phone. At the end of the 15th day, the participants will be interviewed face-to-face again, the follow-up form will be collected and the menopause symptoms and quality of life scales will be re-administered.
Treatment:
Other: Mandala coloring
The control group
No Intervention group
Description:
The control group will be informed about the study in face-to-face interviews with women who applied to the outpatient clinic and were diagnosed with menopause, and women who agreed to participate in the study will be given an informed consent form, a personal information form, and menopause-specific quality of life and menopause symptom assessment scales and asked to fill them out. The women will be interviewed again 15 days later and given the menopause-specific quality of life and menopause symptom assessment scales again and asked to fill them out. In addition, the benefits of the mandala application will be explained to the women in order to eliminate the ethical dilemma, and coloring pencils with mandalas will be given to women who want to do the application. The women's routine care and treatments will continue during the data collection period.

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Emine Karacan, Asst Prof; Emine Karacan, Asst Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems